Top Buys by Directors: Lucier's $310.1K Bet on XRAY

The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both. So in this series we look at the largest insider buys by company directors over the trailing six month period, one of which was a total of $310.1K invested across 2 purchases by Gregory T. Lucier, Director at DENTSPLY SIRONA Inc (Symbol: XRAY).

Lucier's average cost works out to $21.82/share. In trading on Wednesday, bargain hunters could buy shares of DENTSPLY SIRONA Inc (Symbol: XRAY) and achieve a cost basis lower than Lucier, with shares changing hands as low as $19.72 per share. Shares of DENTSPLY SIRONA Inc were changing hands at $20.28 at last check, trading up about 3.7% on Wednesday. The chart below shows the one year performance of XRAY shares, versus its 200 day moving average:

Looking at the chart above, XRAY's low point in its 52 week range is $17.21 per share, with $37.60 as the 52 week high point — that compares with a last trade of $20.28.

The current annualized dividend paid by DENTSPLY SIRONA Inc is $0.64/share, currently paid in quarterly installments, and its most recent dividend ex-date was on 09/27/2024. Below is a long-term dividend history chart for XRAY, which can be of good help in judging whether the most recent dividend with approx. 3.3% annualized yield is likely to continue.

Click here to find out which other top insider buys by company directors you need to know about »

Also see:

• Stock Buybacks
• LCNB market cap history
• Hormel Foods Historical PE Ratio

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.